The following is a summary of “Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy,” published in the January 2025 ...

A recent study found that the triple-layer sign (TLS) obtained on optical coherence tomography has high sensitivity and ...

—The large economic burden from late-stage age-related macular degeneration on patients, caregivers, and healthcare systems is from direct and indirect medical expenses, including well-being and ...

The large economic burden from late-stage age-related macular degeneration on patients, caregivers, and healthcare systems is from direct and indirect medical expenses, including well-being and ...

People who develop macular degeneration often begin experiencing symptoms after 50 years old, but symptoms can happen earlier or later depending on conditions and risk factors. Share on Pinterest ...

Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...

But your vision loss that you think is normal, may be an advanced form of macular degeneration, or loss of vision. Geographic atrophy, also known as GA, is a form of advanced dry macular ...

But your vision loss that you think is normal, may be an advanced form of macular degeneration, or loss of vision. Geographic atrophy, also known as GA, is a form of advanced dry macular ...

Astellas Pharma Inc. announced the US Food and Drug Administration (FDA) accepted the revised supplemental New Drug Application (sNDA) for Izervay (avacincaptad pegol intravitreal solution) for the ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal changes in the macular, resulting in reduced vision and distorted objects.